僅用于工業(yè)應(yīng)用或科學(xué)研究，不可用于人類或動物的臨床診斷或治療，非藥用. Suvratoxumab （MEDI4893） is a long-acting, high-affinity humanized anti-α-toxin monoclonal antibody （IgG1κ type）. Suvratoxumab potently neutralizes α-toxin, a key S. aureus virulence factor. Suvratoxumab improves survival and reduces lung injury in an immunocompromised mice model of pneumonia. Suvratoxumab also enhances the antibacterial activity of Vancomycin （HY-B0671） or Linezolid （HY-10394）